logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
C

Chan Y. Cheah

Sir Charles Gairdner Hospital

48H-index
466Paper Count
9.3KCitation Count
Published Papers 80
Publication Date
logo
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO
errBlood Advances
IF7.1
err2026-06-13
err0
errOAAI
errJeremy S. Abramson; William Townsend; Christopher P. Fox; Matthew Ku; Mark Hertzberg; Hui-Qiang Huang; Huilai Zhang; Dok Hyun Yoon; Won-Seog Kim; Haifaa Abdulhaq; Charles Herbaux; Jan M. Zaucha; Qing-Yuan Zhang; Hung Chang; Yanyan Liu; Chan Yoon Cheah; Herve Ghesquieres; Estefania Mulvihill; Murali Kesavan; Martine Kallemeijn
errShare
errSave
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study
errHemaSphere
IF14.6
err2026-06-07
err0
errOAAI
errChan Y. Cheah; Piers Blombery; Amanda Johnston; Joel Wight; Katharine L. Lewis; Rory Bennett; Jing Xie; Stella Vlachos; Sally M. Hunter; Joyce Gonzales; Sally Binks; John F. Seymour
errShare
errSave
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy
errBlood
IF23.1
err2026-04-16
err0
PREAI
errProkop Vodička; Tarec Christoffer El-Galaly; Vít Procházka; Christopher R Flowers; Diego Villa; Caroline E Dietrich; Lasse H Jakobsen; Hervé Ghesquières; Michael R Clausen; Robert Kridel; Chan Y Cheah; Eliza A Hawkes; Björn Wahlin; Maher K Gandhi; Melissa C Larson; Elliot J Cahn; Jonathan W Friedberg; Peter Martin; Dai Chihara; Jonathon B Cohen
errShare
errSave
Pretransplant promise for PD-1 in Hodgkin lymphoma
errBlood
IF23.1
err2026-03-05
err0
PREAI
errGhassan Zammar; Chan Y. Cheah
errShare
errSave
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.
errBlood Advances
IF7.1
err2026-02-09
err0
errOAAI
errKatharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
errShare
errSave
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study
errBlood Advances
IF7.1
err2026-01-20
err0
errOAAI
errKrish Patel; Julie Vose; Sunita D. Nasta; Jennifer R. Brown; Kami Maddocks; Jennifer Woyach; Nirav N. Shah; Bita Fakhri; Benoit Tessoulin; Shuo Ma; Deepa Jagadeesh; Ewa Lech-Maranda; Catherine C. Coombs; Manish R. Patel; Joanna M. Rhodes; Chaitra Ujjani; Marc S. Hoffmann; Chan Y. Cheah; Talha Munir; David Lewis
errShare
errSave
Approaches to the management of relapsed/refractory mantle cell lymphoma: navigating an increasingly complex therapeutic landscape
errExpert Review of Hematology
IF2.1
err2026-01-01
err1
PREAI
errNoor, Wan Danial; Villa, Diego; Cheah, Chan Yoon
errShare
errSave
T-cell/histiocyte-rich large B-cell lymphoma in the era of novel immunotherapy: A focused review
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-12-01
err0
PREAI
errChoy, Joleen P.; Cheah, Chan Y.
errShare
errSave
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
errHemaSphere
IF14.6
err2025-10-22
err0
errOAAI
errMats Jerkeman; Igor Aurer; Elias Campo; Chan Y. Cheah; Jonathan Clark; Jeanette Doorduijn; Toby A. Eyre; Martin Fehr; Eva Giné; Maria Gomes da Silva; Pavel Klener; Marco Ladetto; Vincent Ribrag; Ofer Shpilberg; Jan Walewski; Martin Dreyling; the EHA Guidelines Committee and the European MCL Network
errShare
errSave
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
errBlood
IF23.1
err2025-10-10
err0
errOAAI
errJennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
errShare
errSave
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-10-01
err0
PREAI
errFasser, Daniel; Joy, Greta; Dowling, Mark R.; Bavishi, Ketan; Ovlisen, Andreas Kiesbye; Choi, Philip; P'ng, Stephanie; Filshie, Robin; Ritchie, David; Bilmon, Ian; Prince, H. Miles; Wolf, Max; Hertzberg, Mark; Chuah, Hun; El-Galaly, Tarec; Tam, Constantine; Seymour, John; Villa, Diego; Cheah, Chan Y.; Lewis, Katharine L.
errShare
errSave
Recent advances and future directions in newly diagnosed mantle cell lymphoma
errEXPERT OPINION ON PHARMACOTHERAPY
IF2.7
err2025-09-01
err0
PREAI
errNoor, Wan Danial; Cheah, Chan Yoon
errShare
errSave
Meeting trial eligibility in Follicular lymphoma patients is associated with overall survival but not progression-free survival
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2025-09-01
err1
PREAI
errWong, Kimberly S. Q.; Martynchyk, Arina; Krisnadi, Zoe; Swain, Fiona; Zargari, Ahmad; Cassidy, Luke; Mills, Georgia; Lim, Kenneth; Gervasi, Jeremy; Smallbone, Portia; Wang, Jenny; Slifirski, Olivia; Loh, Zoe; Cheah, Chan; Keane, Colm; Gregory, Gareth; Lasica, Masa; Chong, Geoffrey; Barraclough, Allison; Cochrane, Tara; Lee, Denise; Hawkes, Eliza
errShare
errSave
The bispecific antibody AZD0486: an overview of the clinical journey to date with a focus on follicular lymphoma
errEXPERT OPINION ON INVESTIGATIONAL DRUGS
IF4.1
err2025-05-06
err0
PREAI
errHambleton, Harry; Cheah, Chan Y.
errShare
errSave
Primary testicular lymphoma
errCANCER TREATMENT REVIEWS
IF10.5
err2025-05-01
err0
PREAI
errGrainger, Brian T.; Cheah, Chan Y.
errShare
errSave
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia
errBlood
IF23.1
err2025-04-12
err0
PREAI
errBrian T. Grainger; Philip A. Thompson; Chan Y. Cheah
errShare
errSave
The End of the Golden Weather: therapeutic strategies for mantle cell lymphoma relapsed or refractory to covalent BTK inhibitors
errHAEMATOLOGICA
IF7.9
err2024-11-14
err0
errOAAI
errGrainger, Brian T.; Cheah, Chan Y.
errShare
errSave
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory (R/R) Indolent NHL: Results from the Phase 1 CaDAnCe-101 Study
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errTam, Constantine S.; Frustaci, Anna Maria; Bijou, Fontanet; Zinzani, Pier Luigi; Seymour, John F.; Lasica, Masa; Eradat, Herbert A.; Lin, Victor T. G.; Alwan, Maan; Mocanu, Irina; Chen, Xiangmei; By, Kunthel; Fabre, Shannon; Persky, Daniel O.; Agarwal, Amit; Cheah, Chan Y.
errShare
errSave
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSungur, Serif; Yao, Yao; Wellard, Cameron; Chung, Eliza; Morgan, Susan; Lee, Denise; Chong, Geoffrey; Cheah, Chan Y.; Rizvi, Tasneem; Hawkes, Eliza A.; Mcquilten, Zoe K.; Wood, Erica M.; Hamad, Nada; Armytage, Tasman; Johnston, Anna M.
errShare
errSave
Obinutuzumab, Lenalidomide and Venetoclax for the Initial Treatment of Patients with Advanced-Stage FollicularLymphoma: Primary Analysis of an Investigator-Initiated Phase Ib/II, Multicenter Study(LEVERAGE)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCheah, Chan Y.; Johnston, Amanda Jane; Wight, Joel; Blombery, Piers; Lewis, Katharine L.; Bennett, Rory; Xie, Jing; Vlahos, Stella; Gonzales, Joyce; Binks, Sally; Seymour, John F.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
D
David Cunningham
H-index: 153 · Papers: 2.1K
R
Richard E. Champlin
H-index: 147 · Papers: 2.1K
W
William G. Wierda
H-index: 121 · Papers: 1.5K
J
Joseph M. Connors
H-index: 120 · Papers: 788
View more